Status:
UNKNOWN
The Effectiveness of Eldecalcitol in the Bisphosphonate Non-respondered-patients With Osteoporosis
Lead Sponsor:
Shinshu University
Conditions:
Osteoporosis
Eligibility:
All Genders
Phase:
PHASE1
Brief Summary
In the patients with osteoporosis, bisphosphonates (BPs) are a golden standard treatment. However, the bone turnover markers or the bone mineral density (BMD) are not improved in some osteoporotic pat...
Detailed Description
Alfacalcitol and Eldecalcitol are the similar vitamin D drugs. However, Eldecalcitol is an improved vitamin D drug than Alfacalcitol. Therefore, we investigate the effectiveness of Eldecalcitol in thi...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Osteoporosis
- Must be able to swallow tablets
Exclusion
- N/A
Key Trial Info
Start Date :
December 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02306187
Start Date
December 1 2014
End Date
December 1 2024
Last Update
September 21 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yukio Nakamura
Matsumoto, Nagano, Japan, 3908621